| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | ||||||||
4,951 | 6,777 | 8,529 | 10,254 | 11,394 | 3,869 | 4,816 | 150 | 18 |
Prepaid research and development | ||||||||
743 | 536 | 460 | 271 | 379 | 505 | - | - | - |
Prepaid expenses and other current assets | ||||||||
240 | 359 | 510 | 155 | 279 | 317 | 428 | 30 | 9 |
Total Current Assets | ||||||||
5,935 | 7,673 | 9,500 | 10,680 | 12,053 | 4,692 | 5,245 | 180 | 27 |
Intangible assets, net | ||||||||
6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
Total Other Assets | ||||||||
6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
Total Assets | ||||||||
5,941 | 7,679 | 9,506 | 10,687 | 12,059 | 4,699 | 5,252 | 187 | 34 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | ||||||||
196 | 190 | 776 | 626 | 329 | - | 184 | 481 | 342 |
Accounts payable | ||||||||
- | - | - | - | - | 99 | - | - | - |
Accrued expenses | ||||||||
193 | 348 | - | - | - | 158 | - | - | - |
Senior note, net of discount of $186,397 at September 30, 2018 | ||||||||
- | - | - | - | - | - | 138 | 28 | - |
Senior secured notes (related parties $470,000 at June 30, 2018) | ||||||||
- | - | - | - | - | - | - | 510 | - |
Senior secured bridge note payable, net of discount of $23,363 at December 31, 2017 | ||||||||
- | - | - | - | - | - | 0 | 225 | 351 |
Subordinated notes payable - related parties, net of discount $11,685 at December 31, 2017 | ||||||||
- | - | - | - | - | - | 0 | 0 | 103 |
Convertible notes payable, net of discount of $687 at December 31, 2017 | ||||||||
- | - | - | - | - | - | 0 | 234 | 234 |
Derivative liability | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Total Current Liabilities | ||||||||
389 | 539 | 776 | 626 | 329 | 257 | 322 | 1,480 | 1,032 |
Commitments and contingencies | ||||||||
- | - | - | - | - | - | 0 | 0 | - |
Shareholders' Equity | ||||||||
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at March 31, 2020 and December 31, 2019 | ||||||||
- | - | - | - | - | - | 0 | 0 | - |
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 10,629,603 and 10,368,352 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively | ||||||||
10 | 10 | 10 | 10 | 10 | 6 | 6 | 3 | 3 |
Additional paid in capital | ||||||||
28,444 | 27,757 | 27,287 | 26,903 | 26,438 | 16,469 | 15,689 | 1,278 | -596 |
Accumulated deficit | ||||||||
-22,903 | -20,626 | -18,568 | -16,852 | -14,718 | -12,035 | -10,766 | -2,575 | -403 |
Total Shareholders' Equity | ||||||||
5,551 | 7,140 | 8,729 | 10,060 | 11,730 | 4,441 | 4,929 | -1,293 | -997 |
Total Liabilities and Shareholders' Equity | ||||||||
5,941 | 7,679 | 9,506 | 10,687 | 12,059 | 4,699 | 5,252 | 187 | 34 |